You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0442 Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Psoriatic arthritis
THU0442 Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gossec L, Kvien T, Conaghan P, et al
THU0442 Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab
Annals of the Rheumatic Diseases 2016;75:351.